title: Metabolism and function of 3-D-phosphorylated phosphoinositides in C5a-stimulated eosinophils.
abstract: Eosinophils play a central role in the pathogenesis of parasitic infections, atopic diseases, and bullous dermatoses. To understand the regulative function of phosphatidylinositol 3-kinases in cell responses of eosinophils, phospholipid metabolism and production of reactive oxygen metabolites were followed after stimulation with C5a. Measurements of phosphatidylinositol lipids and analysis of deacylated products of separated lipid extracts showed fast and transient formation of phosphatidylinositol 3,4,5-trisphosphate (PIP(3)). Cell studies in the presence of the tyrosine kinase blocker genistein indicated that C5a-stimulated PIP(3) formation occurred independently of tyrosine kinase activity. To analyze the function of PI4,5P(2)-3-kinase in eosinophils, the influence of wortmannin and LY294002 on production of reactive oxygen metabolites was studied. Both compounds inhibited with similar concentration dependency C5a-induced formation of PIP(3) and production of reactive oxygen metabolites. In summary, these data showed for the first time the involvement of PI4,5P(2)-3-kinase in the production of reactive oxygen metabolites in eosinophils.
authors.affiliation: Department of Dermatology, University of Freiburg, Freiburg, D-79104, Germany.
authors.forename: C
authors.initials: C
authors.lastname: Hofmann
authors.forename: S
authors.initials: S
authors.lastname: Dichmann
authors.forename: U
authors.initials: U
authors.lastname: Zimpfer
authors.forename: W
authors.initials: W
authors.lastname: Czech
authors.forename: Y
authors.initials: Y
authors.lastname: Herouy
authors.forename: E
authors.initials: E
authors.lastname: Wagner
authors.forename: J
authors.initials: J
authors.lastname: Norgauer
mesh_terms: D000730:Androstadienes / Q000494:pharmacology; D002867:Chromones / Q000494:pharmacology; D015936:Complement C5a / Q000494:pharmacology / Q000502:physiology*; D004791:Enzyme Inhibitors / Q000494:pharmacology; D004804:Eosinophils / Q000187:drug effects / Q000378:metabolism / Q000502:physiology*; D019833:Genistein / Q000494:pharmacology; D006801:Humans; D066298:In Vitro Techniques; D007700:Kinetics; D008163:Luminescent Measurements; D009025:Morpholines / Q000494:pharmacology; D010710:Phosphates / Q000097:blood; D018129:Phosphatidylinositol Phosphates / Q000097:blood*; D010716:Phosphatidylinositols / Q000097:blood*; D010766:Phosphorylation; D017853:Phosphotransferases (Alcohol Group Acceptor) / Q000097:blood; D011505:Protein-Tyrosine Kinases / Q000037:antagonists & inhibitors; D000077191:Wortmannin
chemical_list: D000730:Androstadienes; D002867:Chromones; D004791:Enzyme Inhibitors; D009025:Morpholines; D010710:Phosphates; D018129:Phosphatidylinositol Phosphates; D010716:Phosphatidylinositols; C060974:phosphatidylinositol 3,4,5-triphosphate; C085911:2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one; D015936:Complement C5a; D019833:Genistein; D017853:Phosphotransferases (Alcohol Group Acceptor); C020077:1-phosphatidylinositol-4-phosphate 5-kinase; D011505:Protein-Tyrosine Kinases; D000077191:Wortmannin